Among the main reasons for this failure are the lack of classical T-attractive chemokines (e.g., CXCL9 and CXCL10), the dense tumor microenvironment matrix and the higher tumor-antigen heterogeneity, as compared to hematologic tumors. This evidence concerns the gene CXCL10 and neoplasm.